276 related articles for article (PubMed ID: 17532764)
41. Serum transferrin receptor, ferritin, and reticulocyte maturity indices during the first year of life in 'large' preterm infants.
Schiza V; Giapros V; Pantou K; Theocharis P; Challa A; Andronikou S
Eur J Haematol; 2007 Nov; 79(5):439-46. PubMed ID: 17916083
[TBL] [Abstract][Full Text] [Related]
42. [Myelodisplasic syndromes diagnosed in a geriatric hospital: morphological profile in 100 patients].
Dewulf G; Gouin I; Pautas E; Gaussem P; Chaïbi P; Andreux JP; Siguret V
Ann Biol Clin (Paris); 2004; 62(2):197-202. PubMed ID: 15047472
[TBL] [Abstract][Full Text] [Related]
43. The effects of physical exercise on the concentrations of ferritin and transferrin receptor in plasma of male judoists.
Malczewska J; Stupnicki R; Błach W; Turek-Lepa E
Int J Sports Med; 2004 Oct; 25(7):516-21. PubMed ID: 15459832
[TBL] [Abstract][Full Text] [Related]
44. Transferrin receptor in serum. A new tool in the diagnosis and prevention of iron deficiency in blood donors.
Flesland O; Eskelund AK; Flesland AB; Falch D; Solheim BG; Seghatchian J
Transfus Apher Sci; 2004 Aug; 31(1):11-6. PubMed ID: 15294189
[TBL] [Abstract][Full Text] [Related]
45. Serum transferrin receptor concentration is not indicative of erythropoietic activity in chronic hemodialysis patients with poor response to recombinant human erythropoietin.
Hou CC; Wu SC; Wu SC; Yang WC; Huang TP; Ng YY
Zhonghua Yi Xue Za Zhi (Taipei); 1998 Aug; 61(8):456-62. PubMed ID: 9745161
[TBL] [Abstract][Full Text] [Related]
46. [Clinical significance of red cell ferritin H and L subunits in myelodysplastic syndrome].
Kobayashi T
Hokkaido Igaku Zasshi; 1994 May; 69(3):587-99. PubMed ID: 7927183
[TBL] [Abstract][Full Text] [Related]
47. Levels of soluble forms of ICAM and VCAM in patients with myelodysplastic syndromes and their prognostic significance.
Passam FH; Tsirakis G; Boula A; Fragou A; Consolas I; Alegakis A; Kyriakou DS; Alexandrakis MG
Clin Lab Haematol; 2004 Dec; 26(6):391-5. PubMed ID: 15595996
[TBL] [Abstract][Full Text] [Related]
48. Determination of reference values for the soluble transferrin receptor (sTfR) on a cross sectional population sample.
von Schmiesing A; Schmidt SA; Kratzer W; Mason RA; Imhof A; Steinbach G; Akinli AS; Haenle MM;
Clin Lab; 2009; 55(5-6):193-9. PubMed ID: 19728552
[TBL] [Abstract][Full Text] [Related]
49. Serum erythropoietin and circulating transferrin receptor in thalassemia intermedia patients with heterogeneous genotypes.
Camaschella C; Gonella S; Calabrese R; Vischia F; Roetto A; Graziadei G; Mazza U; Cappellini MD
Haematologica; 1996; 81(5):397-403. PubMed ID: 8952151
[TBL] [Abstract][Full Text] [Related]
50. Iron deficiency anemia increases nitric oxide production in healthy adolescents.
Choi JW; Pai SH; Kim SK; Ito M; Park CS; Cha YN
Ann Hematol; 2002 Jan; 81(1):1-6. PubMed ID: 11807627
[TBL] [Abstract][Full Text] [Related]
51. Amifostine in the treatment of low-risk myelodysplastic syndromes.
Grossi A; Fabbri A; Santini V; Leoni F; Nozzoli C; Longo G; Pagliai G; Ciolli S; Rossi Ferrini P
Haematologica; 2000 Apr; 85(4):367-71. PubMed ID: 10756361
[TBL] [Abstract][Full Text] [Related]
52. Serum soluble transferrin receptor concentration is an accurate estimate of the mass of tissue receptors.
R'zik S; Beguin Y
Exp Hematol; 2001 Jun; 29(6):677-85. PubMed ID: 11378262
[TBL] [Abstract][Full Text] [Related]
53. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].
Wu LY; Li X; Chang CK; Ying SX; Pu Q
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133
[TBL] [Abstract][Full Text] [Related]
54. [Auto- and alloreactivity of T lymphocytes in myelodysplastic syndrome].
Cukrová V; Neuwirtová R; Bartůnková J; Jonásová A; Cermák J; Homolková H; Malíková I
Cas Lek Cesk; 2006; 145(8):647-52; discussion 653. PubMed ID: 16995421
[TBL] [Abstract][Full Text] [Related]
55. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes.
Germing U; Strupp C; Kuendgen A; Isa S; Knipp S; Hildebrandt B; Giagounidis A; Aul C; Gattermann N; Haas R
Haematologica; 2006 Dec; 91(12):1596-604. PubMed ID: 17145595
[TBL] [Abstract][Full Text] [Related]
56. Soluble transferrin receptor following bone marrow transplantation from donors heterozygous for beta thalassemia.
Centis F; Delfini C; Agostinelli F; Tonucci P; Gaziev J; Annibali M; Lucarelli G
Haematologica; 1994; 79(5):448-51. PubMed ID: 7843631
[TBL] [Abstract][Full Text] [Related]
57. DNA instability in low-risk myelodysplastic syndromes: refractory anemia with or without ring sideroblasts.
Novotna B; Neuwirtova R; Siskova M; Bagryantseva Y
Hum Mol Genet; 2008 Jul; 17(14):2144-9. PubMed ID: 18430715
[TBL] [Abstract][Full Text] [Related]
58. Soluble transferrin receptors and ferritin in Type 2 diabetic patients.
Hernández C; Lecube A; Carrera A; Simó R
Diabet Med; 2005 Jan; 22(1):97-101. PubMed ID: 15606699
[TBL] [Abstract][Full Text] [Related]
59. Soluble transferrin receptor and mutations in hemochromatosis and transferrin genes in a general Catalan population.
Bérez V; Camps J; Arija V; Aranda N; Fernández-Ballart J; Vilella E; Figuera L; Ferré N; Joven J
Clin Chim Acta; 2005 Mar; 353(1-2):205-8. PubMed ID: 15698609
[TBL] [Abstract][Full Text] [Related]
60. The responses of serum transferrin receptors to iron supplements in subjects with iron-deficiency erythropoiesis and iron-deficiency anaemia.
Lin XM; Tian W; Ma L; Long Z; Zhang J; Shen XY; Zhang XP
Br J Nutr; 2008 Feb; 99(2):416-20. PubMed ID: 17868487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
